Genevieve M. Boland

28.5k total citations · 7 hit papers
121 papers, 5.6k citations indexed

About

Genevieve M. Boland is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Genevieve M. Boland has authored 121 papers receiving a total of 5.6k indexed citations (citations by other indexed papers that have themselves been cited), including 85 papers in Oncology, 55 papers in Molecular Biology and 36 papers in Immunology. Recurrent topics in Genevieve M. Boland's work include Cancer Immunotherapy and Biomarkers (46 papers), CAR-T cell therapy research (29 papers) and Immunotherapy and Immune Responses (27 papers). Genevieve M. Boland is often cited by papers focused on Cancer Immunotherapy and Biomarkers (46 papers), CAR-T cell therapy research (29 papers) and Immunotherapy and Immune Responses (27 papers). Genevieve M. Boland collaborates with scholars based in United States, China and Australia. Genevieve M. Boland's co-authors include Rocky S. Tuan, Richard Tuli, Géraldine Perkins, Dennie T. Frederick, David J. Hall, Ronald J. Weigel, Keith T. Flaherty, Leslie M. Fischer, Ryan J. Sullivan and Jennifer A. Lo and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Genevieve M. Boland

105 papers receiving 5.5k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Adult mesenchymal stem cells and cell-based tissue engineering.

2003 602 citations Genevieve M. Boland et al. profile →
Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma

2018 456 citations Dennie T. Frederick, Benchun Miao et al. profile →
Intratumoral Activity of the CXCR3 Chemokine System Is Required for the Efficacy of Anti-PD-1 Therapy

2019 438 citations Dennie T. Frederick, David E. Fisher et al. profile →
The Human and Mouse Enteric Nervous System at Single-Cell Resolution

2020 337 citations Tatyana Sharova, Genevieve M. Boland et al. profile →
Lineage Tracing in Humans Enabled by Mitochondrial Mutations and Single-Cell Genomics

2019 325 citations Leif S. Ludwig, Caleb A. Lareau et al. profile →
Molecular Pathways of Colon Inflammation Induced by Cancer Immunotherapy

2020 307 citations Tatyana Sharova, Ryan J. Sullivan et al. profile →
Defining clinically useful biomarkers of immune checkpoint inhibitors in solid tumours

2024 112 citations Aikaterini Dedeilia, Kailan Sierra-Davidson et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Genevieve M. Boland United States	30	2.3k	2.1k	1.4k	781	744	121	5.6k
Franklin Peale United States	36	1.9k 0.8×	3.8k 1.8×	1.3k 0.9×	617 0.8×	1.3k 1.7×	70	7.6k
Brett M. Hall United States	22	2.1k 0.9×	2.0k 0.9×	698 0.5×	528 0.7×	1.0k 1.4×	43	4.7k
Christian F. Guerrero‐Juarez United States	22	1.1k 0.5×	2.8k 1.3×	1.9k 1.4×	495 0.6×	743 1.0×	32	6.2k
Giuseppe Pirozzi Italy	39	1.6k 0.7×	2.0k 1.0×	685 0.5×	1.1k 1.5×	787 1.1×	94	5.7k
Katherine N. Weilbaecher United States	46	3.2k 1.4×	2.5k 1.2×	1.3k 0.9×	375 0.5×	817 1.1×	124	6.1k
Kairbaan Hodivala‐Dilke United Kingdom	50	2.0k 0.9×	5.3k 2.5×	1.4k 1.0×	793 1.0×	1.6k 2.2×	107	9.7k
Cornelia Mauch Germany	49	3.0k 1.3×	2.7k 1.3×	1.4k 1.0×	405 0.5×	1.4k 1.9×	208	7.9k
Marc Schmitz Germany	46	2.8k 1.2×	2.0k 0.9×	3.2k 2.3×	431 0.6×	440 0.6×	173	6.4k
Tetsuro Watabe Japan	44	1.7k 0.7×	4.6k 2.1×	609 0.4×	821 1.1×	787 1.1×	108	6.9k
Yasuyuki Morishita Japan	47	2.6k 1.1×	4.0k 1.9×	1.9k 1.3×	671 0.9×	1.1k 1.5×	94	7.9k

Countries citing papers authored by Genevieve M. Boland

Since Specialization

Citations

This map shows the geographic impact of Genevieve M. Boland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Genevieve M. Boland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Genevieve M. Boland more than expected).

Fields of papers citing papers by Genevieve M. Boland

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Genevieve M. Boland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Genevieve M. Boland. The network helps show where Genevieve M. Boland may publish in the future.

Co-authorship network of co-authors of Genevieve M. Boland

This figure shows the co-authorship network connecting the top 25 collaborators of Genevieve M. Boland. A scholar is included among the top collaborators of Genevieve M. Boland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Genevieve M. Boland. Genevieve M. Boland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Oliveira, Solange, Nayara Gusmão Tessarollo, Ana Paula Lepique, et al.. (2025). Use of patient-derived organotypic tumor spheroids for testing of viral vector gene therapy in combination with checkpoint blockade. PubMed. 33(1). 200942–200942. 1 indexed citations

Sierra-Davidson, Kailan & Genevieve M. Boland. (2024). Advances in Adjuvant and Neoadjuvant Therapy for Melanoma. Hematology/Oncology Clinics of North America. 38(5). 953–971. 1 indexed citations

Sierra-Davidson, Kailan, Aikaterini Dedeilia, Aleigha Lawless, et al.. (2024). Genetic Factors Associated with Clinical Response in Melanoma Patients Treated with Talimogene Laherparapvec: A Single-Institution Retrospective Analysis. Annals of Surgical Oncology. 32(1). 482–494. 2 indexed citations

Moonsamy, Philicia, et al.. (2024). Pulmonary Metastasectomy for Melanoma. Thoracic surgery clinics/Thorac. surg. clin.. 35(2). 223–231. 1 indexed citations

Kochis, Michael, David C. Cron, Taylor M. Coe, et al.. (2024). Implementation and Evaluation of an Academic Development Rotation for Surgery Residents. Journal of surgical education. 81(11). 1748–1755. 1 indexed citations

Thierauf, Julia, Stefan T. Kaluziak, Aikaterini Dedeilia, et al.. (2023). Prognostic biomarkers for survival in mucosal melanoma.. Journal of Clinical Oncology. 41(16_suppl). e21576–e21576.

Lwin, Thinzar M., et al.. (2023). Surgical Utilization and Outcomes for Patients with Stage IV Melanoma in the Modern Immunotherapy Era. Annals of Surgical Oncology. 30(8). 5005–5012. 6 indexed citations

Kanaya, Nobuhiko, Yohei Kitamura, Kok‐Siong Chen, et al.. (2023). Gene-edited and -engineered stem cell platform drives immunotherapy for brain metastatic melanomas. Science Translational Medicine. 15(698). eade8732–eade8732. 13 indexed citations

Cattaneo, Giulia, Jingyu Jia, Luke Maggs, et al.. (2023). 317 B7-H3-targeted CAR T cell with an inducible caspase 9 suicide gene effectively eradicates uveal melanoma liver metastases. SHILAP Revista de lepidopterología. A360–A360. 1 indexed citations

10.

Xu, Gege, Rachel Rice, Yana G. Najjar, et al.. (2023). Plasma glycoproteomic biomarkers identify metastatic melanoma patients with reduced clinical benefit from immune checkpoint inhibitor therapy. Frontiers in Immunology. 14. 1187332–1187332. 9 indexed citations

11.

Fox, Douglas B., Richard Y. Ebright, Xin Hong, et al.. (2023). Downregulation of KEAP1 in melanoma promotes resistance to immune checkpoint blockade. npj Precision Oncology. 7(1). 25–25. 7 indexed citations

12.

Ručević, Marijana, Arnav Mehta, Emmett Sprecher, et al.. (2023). 152 Immuno-oncology protein biomarker panels provide greater biological insights and improved patient stratification. SHILAP Revista de lepidopterología. A172–A172.

13.

Lwin, Thinzar M., et al.. (2023). ASO Visual Abstract: Surgical Utilization and Outcomes for Patients with Stage 4 Melanoma in the Modern Immunotherapy Era. Annals of Surgical Oncology. 30(8). 5015–5016.

14.

Sharma, Samanta, Tian Zhang, Wojciech Michowski, et al.. (2020). Targeting the cyclin-dependent kinase 5 in metastatic melanoma. Proceedings of the National Academy of Sciences. 117(14). 8001–8012. 17 indexed citations

15.

Lareau, Caleb A., Leif S. Ludwig, Christoph Muus, et al.. (2020). Massively parallel single-cell mitochondrial DNA genotyping and chromatin profiling. Nature Biotechnology. 39(4). 451–461. 178 indexed citations

16.

Larimer, Benjamin M., et al.. (2018). The Effectiveness of Checkpoint Inhibitor Combinations and Administration Timing Can Be Measured by Granzyme B PET Imaging. Clinical Cancer Research. 25(4). 1196–1205. 93 indexed citations

17.

Weber, Jeffrey S., Mario Sznol, Ryan J. Sullivan, et al.. (2017). A Serum Protein Signature Associated with Outcome after Anti–PD-1 Therapy in Metastatic Melanoma. Cancer Immunology Research. 6(1). 79–86. 53 indexed citations

18.

Larimer, Benjamin M., Eric Wehrenberg-Klee, Frank Dubois, et al.. (2017). Granzyme B PET Imaging as a Predictive Biomarker of Immunotherapy Response. Cancer Research. 77(9). 2318–2327. 240 indexed citations

19.

Nardi, Valentina, Youngchul Song, Juan A. Santamaria‐Barria, et al.. (2012). Activation of PI3K Signaling in Merkel Cell Carcinoma. Clinical Cancer Research. 18(5). 1227–1236. 87 indexed citations

20.

Boland, Genevieve M. & Ronald J. Weigel. (2006). Formation and Prevention of Postoperative Abdominal Adhesions. Journal of Surgical Research. 132(1). 3–12. 179 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact